Status:
ENROLLING_BY_INVITATION
Systemic Effects of A Continuous Blood Flow Restricted Aerobic Exercise Session in COPD Patients: A Randomised Controlled Trial.
Lead Sponsor:
Medipol University
Conditions:
COPD
Eligibility:
MALE
40-75 years
Phase:
NA
Brief Summary
Patients with COPD that a pulmonologist classifies between Stage 1-2 in accordance with the GOLD criteria and age and gender-matched healthy individuals will be included in the study. In both groups ...
Detailed Description
Target heart rate will be calculated from the formula "(Maximal heart rate-resting heart rate) x% desired intensity ratio + resting heart rate". The target occlusion amount in the lower extremity wil...
Eligibility Criteria
Inclusion
- No drug change for at least 30 days for the COPD group
- Not participating in a structured activity program for at least six months
- Have the ability to cooperate
Exclusion
- Presence of any pathology that limits physical activity performance
- Presence of severe or unstable heart disease
- Presence of peripheral artery disease
- Being in an exacerbation period of the disease
- Presence of another active disease (rheumatic, oncological, traumatic etc.)
- Any neurological or orthopedic disease that prevents exercise
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 15 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04526184
Start Date
August 17 2020
End Date
April 15 2024
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karabük Üniversitesi Araştırma Hastanesi Göğüs Hastalıkları Kliniği
Karabük, Turkey (Türkiye), 78600